TP53 and breast carcinoma: However, within the subset examined (i.e., 49 randomly extracted breast cancer patients), raw agreement between results from immunohistochemestry and sequencing was quite satisfactory in the p53 positive group (53.3%) and high in the p53 negative group (73.7%).